Sandu Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.66 Cr
- Company Age 39 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 53.06 Cr
- Revenue Growth 0.14%
- Profit Growth -4.13%
- Ebitda -13.39%
- Net Worth 7.59%
- Total Assets 9.91%
About Sandu Pharmaceuticals
Sandu Pharmaceuticals Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 15 November 1985 and has a history of 39 years and two months. Its registered office is in Na, Goa.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524703.
The Corporate was formerly known as Sandu Pharmaceuticals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.66 Cr.
The company has closed loans amounting to ₹53.06 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sandu Pharmaceuticals Limited India are Pratika Mhambray as COMPANY SECRETARY and Vijay Kajarekar as Cfo. Shashank Sandu, Umesh Sandu, Shubhada Sandu, and Two other members serve as directors at the Company.
Company Details
-
LocationNa, Goa
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
L24233GA1985PLC001587
-
Company No.
001587
-
Stock Symbol
BSE : 524703
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 1985
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Listed
-
ROC Code
Roc Goa
Industry
What products or services does Sandu Pharmaceuticals Limited offer?
Sandu Pharmaceuticals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, HIV Drugs, Sexual Wellness Products, Contraceptives, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Anti Smoking Drugs.
Who are the key members and board of directors at Sandu Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Sandu
|
Managing Director | 23-Mar-1992 | Current |
|
Pratika Mhambray
|
Company Secretary | 01-Apr-2015 | Current |
| Vijay Kajarekar | CFO | 11-Apr-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shashank Sandu
|
Director | 23-Mar-1992 | Current |
|
Shubhada Sandu
|
Director | 01-Apr-2015 | Current |
|
Balram Viswanathan
|
Director | 14-Aug-2023 | Current |
|
Ajit Kantak
|
Director | 14-Aug-2023 | Current |
Financial Performance of Sandu Pharmaceuticals.
Sandu Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.14% increase. The company also saw a slight decrease in profitability, with a 4.13% decrease in profit. The company's net worth moved up by a moderate rise of 7.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandu Pharmaceuticals?
In 2023, Sandu Pharmaceuticals had a promoter holding of 52.42% and a public holding of 47.59%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹53.06 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 18.00 Cr
- Axis Bank Limited : 17.25 Cr
- Dena Bank : 16.61 Cr
- Dena Bank (Industrial Finance Branch) : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2021 | Hdfc Bank Limited | ₹18.00 Cr | Satisfied |
| 24 Sep 2018 | Axis Bank Limited | ₹14.75 Cr | Satisfied |
| 12 Apr 2011 | Dena Bank | ₹1.91 Cr | Satisfied |
| 21 Dec 2010 | Dena Bank | ₹10.00 Cr | Satisfied |
| 30 Apr 2008 | Axis Bank Limited | ₹2.50 Cr | Satisfied |
How Many Employees Work at Sandu Pharmaceuticals?
Sandu Pharmaceuticals has a workforce of 295 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandu Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandu Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
